Status:
RECRUITING
Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF
Lead Sponsor:
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Conditions:
Infertility
Eligibility:
FEMALE
20-42 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare the clinical outcomes using different cetrorelix acetate in the context of a GnRH antagonist protocol for ovarian stimulation in women undergoing IVF or i...
Eligibility Criteria
Inclusion
- Infertile couples plan to undergo IVF / ICSI pregnancy treatment into screening procedures and clinical study
- All subjects should sign the informed consent form
- Infertile women \<43 years old
- With flexible GnRH antagonist
Exclusion
- Subjects could not enter the study if they meet any one of the following criteria
- Preimplantation Genetic Testing (PGT)
- Untreated hydrosalpinges, moderate or severe endometriosis, recurrent spontaneous miscarriage, endometrial pathology, uterine malformations, etc
- Endocrine diseases (such as hyperthyroidism, hyperprolactinemia, etc.) or other systemic disease and other systemic diseases (such as hypertension, diabetes, etc.)．
- Other factors were considered inappropriate by the investigator to participate, or assisted reproductive technology/pregnancy contraindications
Key Trial Info
Start Date :
February 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1338 Patients enrolled
Trial Details
Trial ID
NCT06023602
Start Date
February 27 2024
End Date
December 1 2025
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
He Cai
Xi'an, None Selected, China